CompoSecure (CMPO) director reports 54,055-share Class A stock acquisition

Rhea-AI Filing Summary

CompoSecure, Inc. director Kevin M. Moriarty reported acquiring 54,055 shares of Class A common stock on January 12, 2026 at $18.50 per share. This increased his directly held position to 67,055 Class A shares. The acquisition is linked to CompoSecure’s completed combination with Husky Technologies Limited, where certain investors purchased Class A shares for $18.50 per share under purchase agreements dated November 2, 2025.

Insider Trade Summary

Net Buyer: 54,055 shares

Net Buy 1 txn

Insider Moriarty Kevin M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	54,055	$18.50	$1.00M

Holdings After Transaction: Class A Common Stock — 67,055 shares (Direct)

Footnotes (1)

1. F1. On January 12, 2026, CompoSecure, Inc. (the "Issuer") completed its previously announced combination with Husky Technologies Limited, including the acquisition by certain investors of shares of the Issuer's Class A common stock, par value $0.0001 per share, for $18.50 per share, pursuant to those certain Purchase Agreements dated November 2, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/14/2026 - 09:12 PM Learn about SEC filing dates

FAQ

What insider transaction did CompoSecure (CMPO) report for January 12, 2026?

CompoSecure reported that director Kevin M. Moriarty acquired 54,055 shares of its Class A common stock on January 12, 2026, as shown in a Form 4 filing.

At what price were the newly acquired CompoSecure (CMPO) shares reported on the Form 4?

The Form 4 states that the 54,055 Class A shares were acquired at a price of $18.50 per share.

How many CompoSecure (CMPO) shares does Kevin M. Moriarty hold after this transaction?

Following the reported transaction, Kevin M. Moriarty beneficially owns 67,055 shares of CompoSecure’s Class A common stock in direct ownership.

What is Kevin M. Moriarty’s relationship to CompoSecure (CMPO)?

The filing identifies Kevin M. Moriarty as a director of CompoSecure, Inc. and confirms the Form 4 is filed by one reporting person.

How is the Husky Technologies Limited combination related to this CompoSecure (CMPO) insider filing?

The footnote explains that on January 12, 2026, CompoSecure completed its combination with Husky Technologies Limited, including the acquisition by certain investors of Class A common stock for $18.50 per share under purchase agreements dated November 2, 2025.

Is Kevin M. Moriarty’s ownership in CompoSecure (CMPO) direct or indirect after the reported transaction?

The Form 4 indicates that the 67,055 Class A shares are held with direct ownership, with no separate indirect ownership entity listed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moriarty Kevin M

(Last) (First) (Middle)

C/O COMPOSECURE, INC.

309 PIERCE STREET

(Street)

SOMERSET NJ 08873

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CompoSecure, Inc. [ CMPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/12/2026		A		54,055	A	$18.5(1)	67,055	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On January 12, 2026, CompoSecure, Inc. (the "Issuer") completed its previously announced combination with Husky Technologies Limited, including the acquisition by certain investors of shares of the Issuer's Class A common stock, par value $0.0001 per share, for $18.50 per share, pursuant to those certain Purchase Agreements dated November 2, 2025.

	/s/ Kevin M. Moriarty, by attorney-in-fact Mary O. Holt	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.